Similarly, 57% of samples in which PTEN was not expressed (4/7) exhibited a mutation in either KRAS or BRAF. Concomitant absence of PTEN staining and the presence of mutant PIK3CA were never observed in the same tumor, but this result was not statistically significant. This evidence concerns the gene KRAS and neoplasm.